Food and Drug Administration (FDA) and European Medicines Agency (EMA) submissions
Molecular weight: ~4731.5 g/mol
[4] [6] In trials, the effects of retatrutide are thought to be mediated through a combination of appetite suppression, increased energy expenditure, and broader metabolic regulation though the precise contribution of each receptor pathway in humans remains under investigation, and long-term cardiovascular and safety outcomes are not yet established
Some view using GLP-1s as promoting thinness culture and eschewing the gains made by the fat-positivity movement, which encourages people to love their larger bodies
In modern Western societies, scurvy is seldom present in average adults, although underfed people (drug users, the homeless, neglected children and geriatrics) are affected
However, the FDA says that when there is a shortage of a particular drug, compounding is allowed to ensure the patient can access treatment